Fresenius Medical Care AG (FMS) Cash & Equivalents (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Cash & Equivalents for 17 consecutive years, with -$1.9 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Equivalents fell 46.99% year-over-year to -$1.9 billion; the TTM figure through Dec 2025 stood at -$1.9 billion (down 46.99% YoY), while the FY2025 annual figure was -$1.9 billion, down 46.99% from the prior year.
• Cash & Equivalents came in at -$1.9 billion for Q4 2025 at Fresenius Medical Care AG, down from $1.5 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $1.9 billion in Q2 2025, with the low at -$1.9 billion in Q4 2025.
• Average Cash & Equivalents over 5 years is $607.1 million, with a median of $1.3 billion recorded in 2021.
• Across the five-year window, Cash & Equivalents sank 201.67% in 2022 and jumped 262.12% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $1.7 billion in 2021, then retreated by 23.33% to $1.3 billion in 2022, then rose by 18.16% to $1.5 billion in 2023, then slumped by 182.46% to -$1.3 billion in 2024, then sank by 46.99% to -$1.9 billion in 2025.
• According to Business Quant data, Cash & Equivalents over the past three periods registered -$1.9 billion, $1.5 billion, and $1.9 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.